MicroSectors FANG and Innovation 3X Leveraged ETN vs IQVIA Holdings Inc. Common Stock — how do they compare? MicroSectors FANG and Innovation 3X Leveraged ETN trades at $36.73 (market cap $2.98B), while IQVIA Holdings Inc. Common Stock trades at $261.78 (market cap $42.61B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 14.3× MicroSectors FANG and Innovation 3X Leveraged ETN's market cap, and IQVIA Holdings Inc. Common Stock is more actively traded (988,398 versus 4,682,352). Which is the better fit depends on your goals — on Pluang, investors hold MicroSectors FANG and Innovation 3X Leveraged ETN for 19 Days and IQVIA Holdings Inc. Common Stock for 1 Days on average.
| FNGU | IQV | |
|---|---|---|
Market Cap | $2.98B | $42.61B |
Volume | 4,682,352 | 988,398 |
Sector | Leveraged / Inverse | Health |
52-Week High | $37.20 | $275.02 |
52-Week Low | $13.73 | $156.66 |
Typical Hold Time | 19 Days | 1 Days |
Enterprise Value | — | $56.77B |
Signals from Pluang's Aura AI — not financial advice
FNGU, a 3x leveraged ETN tracking major tech stocks, trades at $36.62, down 1.56% today. Technical indicators show a bullish trend with strong moving average support, though oscillators remain neutral. The ETN provides triple exposure to tech giants like Nvidia, Meta, and Apple, but carries significant volatility risks as highlighted by recent analysis showing an 87% decline during previous tech sector downturns.
The outlook remains highly speculative given the leveraged structure. While bullish technicals suggest potential upside if tech stocks continue performing, the extreme volatility and historical drawdowns present substantial risk. Investors should weigh the amplified returns against the possibility of rapid losses during market corrections.
No Aura AI signal available yet.
Trailing returns across standard periods
FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.
Read more on FNGU →IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →